Tlando™(testosterone undecanoate) – New drug approval
March 29, 2022 - Antares Pharma announced the FDA approval of Tlando (testosterone undecanoate), for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:
Download PDF
